Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Folate absorption in Crohn's disease

G G Steger1, R M Mader, H Vogelsang

  • 1Department of Internal Medicine I, University of Vienna, Austria.

Digestion
|January 1, 1994
PubMed
Summary

This study tested how well people with Crohn's disease absorb folate from food or supplements. Researchers gave 100 patients and 20 healthy people an oral folate test and measured changes in their blood folate levels. They found that 25 Crohn's patients had abnormal folate absorption. Sixteen of them had partial absorption, and nine had no absorption at all. The test worked well in an outpatient setting and could help doctors decide if patients need more folate in their diet or injections. The results suggest that about 10% of Crohn's patients may need parenteral folate, while others might benefit from dietary changes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concordance between clinician-reported toxicities and patient-reported symptom severity in early-stage breast cancer: an analysis of the randomized phase III PANTHER trial.

ESMO open·2026
Same author

Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13]).

Breast cancer research : BCR·2025
Same author

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

The C/C_₁₃₉₁₀ and G/G_₂₂₀₁₈ Genotypes for Adult-type Hypolactasia are not Associated with Inflammatory Bowel Disease.

Scandinavian journal of gastroenterology·2017
Same author

Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Area of Science:

  • Gastrointestinal absorption research in clinical nutrition
  • Inflammatory bowel disease management

Background:

Folate absorption in patients with Crohn's disease remains poorly understood. Prior research has shown that folate deficiency is common in inflammatory bowel disease, but the mechanisms are unclear. No prior work had resolved how frequently folate absorption is impaired in Crohn's disease patients. Existing knowledge suggests that folate is absorbed primarily in the proximal small intestine, which is often affected in Crohn's disease. However, it was already known that not all patients with Crohn's disease exhibit folate deficiency. This gap motivated the need for a study that could distinguish between impaired absorption and other causes of folate deficiency. The study aimed to determine whether folate absorption is altered in Crohn's disease patients regardless of disease location or severity. Prior studies had not established whether folate absorption could be tested noninvasively. This uncertainty drove the development of a new oral folate absorption test.

Purpose Of The Study:

The goal was to assess the frequency of abnormal folate absorption in Crohn's disease patients. The study focused on whether folate absorption is affected by the location or activity of the disease. A specific problem was to identify a subgroup of patients who may benefit from parenteral folate supplementation. The motivation was to develop a practical outpatient test for detecting folate absorption issues. The researchers aimed to determine if abnormal folate absorption correlates with disease extent or activity. They also wanted to distinguish between partial and complete absorption impairment. The study sought to provide a clinical tool for managing folate deficiency in Crohn's disease. The findings could help guide dietary or supplemental interventions for affected patients.

Keywords:
Folate absorptionCrohn's diseaseOral folate testNutritional deficiency

Frequently Asked Questions

The test identified abnormal folate absorption in 25 of 100 Crohn's disease patients.

Partial absorption was marked by a small increase in serum folate, while complete failure showed no increase.

The test is designed to be quick and practical for routine clinical use in outpatient settings.

Serum folate levels after oral intake help determine whether absorption is impaired or normal.

Related Experiment Videos

Main Methods:

The study involved 100 Crohn's disease patients and 20 healthy controls. An oral folate absorption test was administered to all participants. Serum folate levels were measured after oral folate intake. The test was designed to detect changes in serum folate concentrations. Patients were categorized based on their response to the test. Impaired absorption was defined as insufficient increase in serum folate levels. Complete absorption failure was indicated by no measurable increase. The test was performed in an outpatient setting to ensure practicality.

Main Results:

Abnormal folate absorption was detected in 25 Crohn's disease patients. Sixteen patients showed impaired absorption with a partial increase in serum folate. Nine patients had no detectable increase in serum folate levels after oral intake. The abnormal absorption was not linked to disease extent or activity. No correlation was found between folate absorption and Crohn's disease severity. The test successfully distinguished between normal and abnormal absorption. The results suggest that about 10% of Crohn's patients may need parenteral folate. Dietary adjustments may be sufficient for those with partial absorption issues. The test proved to be a quick and effective outpatient diagnostic tool.

Conclusions:

The study found that abnormal folate absorption occurs in a subset of Crohn's disease patients. The absorption defect was not correlated with disease location or activity. The oral folate absorption test proved to be a useful outpatient diagnostic method. Patients with impaired absorption may benefit from increased dietary folate. Those with complete absorption failure may require parenteral supplementation. The findings suggest that folate deficiency in Crohn's disease may be due to absorption issues. The study does not propose that folate deficiency is always caused by absorption defects. The results may help guide targeted folate supplementation strategies.

Failed At:

2026-07-14T07:44:39.365328+00:00

Nine patients, or about 10%, showed no measurable increase in serum folate levels.

The researchers suggest parenteral folate supplementation for these patients.